Clinical trial
Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
NCT00055991 · Baylor Breast Care Center, Other · Completed
Key facts
| NCT number | NCT00055991 |
|---|---|
| Title | Bexarotene in Preventing Breast Cancer in Women at Genetic Risk |
| Official title | A Multicenter Randomized Double-Blind Trial Of Targretin Capsules Modifying Immunophenotypic Markers Related To Breast Cancer Progression In Breast Tissue From Genetically Identified High Risk Patients |
| Lead sponsor | Baylor Breast Care Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | bexarotene |
| Enrollment | 87 |
| Start date | Sep 1, 2001 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Mar 7, 2003 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: